93155-0 High-Risk Drug Classes: Use and Indication

Observation ID in Form

N0415

Fully-Specified Name

Component

IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication

Property

-

Time

RptPeriod

System

^Patient

Scale

-

Method

CMS Assessment

Basic Attributes

Class

PANEL.SURVEY.CMS

Type

Surveys

First Released

Version 2.67

Last Updated

Version 2.74

Change Reason

Release 2.74: TIME_ASPCT: with current modeling, we no longer specify days/time - replace Pt with ReportPeriod for TIME instead to report assessment periods (eg, 7D) ; Release 2.72: COMPONENT: Updated to include current version of OASIS that uses this panel; Release 2.69: COMPONENT: Updated to include the versions of IRF-PAI and LCDS and use this panel.;

Order vs. Observation

Subset

Panel Type

Organizer

Member of these Panels

Related Names

• Centers for Medicare and Medicaid Assessment
• Drugs
• Outcome and assessment information set
• Pan
• Panel
• PANEL.SURVEY.CMS
• Panl
• Pnl
• Report period
• Survey

Related Codes

93153-5 Is taking

Observation ID in Form

N0415_1

Form Coding Instructions

Check all that apply

Form Coding Instructions

Check if the patient is taking any medications by pharmacological classification, not how it is used, in the following classes

Fully-Specified Name

Component

Drug classes of medications taken

Property

Type

Time

RptPeriod

System

^Patient

Scale

Nom

Method

CMS Assessment

Basic Attributes

Class

SURVEY.CMS

Type

Surveys

First Released

Version 2.67

Last Updated

Version 2.77

Change Reason

Release 2.77: TIME_ASPCT: CMS policy change from Pt to RptPeriod;

Order vs. Observation

Observation

Normative Answer List LL5388-5

Member of these Panels

Related Names

• Addiction
• Centers for Medicare and Medicaid Assessment
• Drugs
• Drugs of abuse
• Illicit
• Nominal
• PotentialForAbuse
• Report period
• Survey
• Typ

Related Codes

93154-3 Indication noted

Observation ID in Form

N0415_2

Form Coding Instructions

If column 1 [Is Taking] is checked, check if there is an indication noted for all medications in the drug class

Form Coding Instructions

Check all that apply

Fully-Specified Name

Component

Drug classes that have an indication documented

Property

Type

Time

RptPeriod

System

^Patient

Scale

Nom

Method

CMS Assessment

Basic Attributes

Class

SURVEY.CMS

Type

Surveys

First Released

Version 2.67

Last Updated

Version 2.77

Change Reason

Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments;

Order vs. Observation

Observation

Normative Answer List LL5415-6

Member of these Panels

Related Names

• Centers for Medicare and Medicaid Assessment
• Drugs
• Nominal
• Report period
• Survey
• Typ

Related Codes

57255-2 Drug Regimen Review: Did a complete drug regimen review identify potential clinically significant medication issues?

Term Description

Indicates whether a drug regimen review indicate potential clinically significant medication issues.
Source: Regenstrief LOINC

Observation ID in Form

N2001

Skip Logic

If 0, skip to O0110, Special Treatments, Procedures, and Programs. If 1, continue to N2003, Medication Follow-up. If 9, skip to O0110, Special Treatments, Procedures, and Programs.

Fully-Specified Name

Component

Drug regimen review identified potential medication issues

Property

Find

Time

RptPeriod

System

^Patient

Scale

Ord

Method

CMS Assessment

Basic Attributes

Class

SURVEY.CMS

Type

Surveys

First Released

Version 2.29

Last Updated

Version 2.77

Change Reason

Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; Previous Releases: Updated METHOD from OASIS-C to CMS Assessment to use term across CMS instruments as approved by the Clinical LOINC committee; Moved Survey Question text to Override Display Name for consistent modeling across CMS forms; Expanded Component to be more precise

Order vs. Observation

Observation

Normative Answer List LL5418-0

Member of these Panels

Related Names

• Centers for Medicare and Medicaid Assessment
• Drugs
• Finding
• Findings
• Ordinal
• Ql
• Qual
• Qualitative
• Report period
• Screen
• Survey

Related Codes

57281-8 Medication Follow-up: Did the facility contact a physician (or physician-designee) by midnight of the next calendar day and complete prescribed/recommended actions in response to the identified potential clinically significant medication issues?

Observation ID in Form

N2003

Fully-Specified Name

Component

Medication follow-up

Property

Find

Time

RptPeriod

System

^Patient

Scale

Ord

Method

CMS Assessment

Basic Attributes

Class

SURVEY.CMS

Type

Surveys

First Released

Version 2.29

Last Updated

Version 2.77

Change Reason

Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; Previous Releases: Updated METHOD from OASIS-C to CMS Assessment to use term across CMS instruments as approved by the Clinical LOINC committee; Moved Survey Question text to Override Display Name for consistent modeling across CMS forms

Order vs. Observation

Observation

Normative Answer List LL251-0

Member of these Panels

Related Names

• Centers for Medicare and Medicaid Assessment
• Finding
• Findings
• Ordinal
• Ql
• Qual
• Qualitative
• Report period
• Screen
• Survey

Related Codes

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.